TY - JOUR
T1 - Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation
AU - Mubaid, Souad
AU - Sanchez, Brenda Janice
AU - Algehani, Rinad A.
AU - Skopenkova, Viktoriia
AU - Adjibade, Pauline
AU - Hall, Derek T.
AU - Busque, Sandrine
AU - Lian, Xian Jin
AU - Ashour, Kholoud
AU - Tremblay, Anne Marie K.
AU - Carlile, Graeme
AU - Gagné, Jean Philippe
AU - Diaz-Gaxiola, Andrea
AU - Khattak, Shahryar
AU - Di Marco, Sergio
AU - Thomas, David Y.
AU - Poirier, Guy G.
AU - Gallouzi, Imed Eddine
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/4/24
Y1 - 2024/4/24
N2 - Poly(ADP-ribosylation) (PARylation) is a post-translational modification mediated by a subset of ADP-ribosyl transferases (ARTs). Although PARylation-inhibition based therapies are considered as an avenue to combat debilitating diseases such as cancer and myopathies, the role of this modification in physiological processes such as cell differentiation remains unclear. Here, we show that Tankyrase1 (TNKS1), a PARylating ART, plays a major role in myogenesis, a vital process known to drive muscle fiber formation and regeneration. Although all bona fide PARPs are expressed in muscle cells, experiments using siRNA-mediated knockdown or pharmacological inhibition show that TNKS1 is the enzyme responsible of catalyzing PARylation during myogenesis. Via this activity, TNKS1 controls the turnover of mRNAs encoding myogenic regulatory factors such as nucleophosmin (NPM) and myogenin. TNKS1 mediates these effects by targeting RNA-binding proteins such as Human Antigen R (HuR). HuR harbors a conserved TNKS-binding motif (TBM), the mutation of which not only prevents the association of HuR with TNKS1 and its PARylation, but also precludes HuR from regulating the turnover of NPM and myogenin mRNAs as well as from promoting myogenesis. Therefore, our data uncover a new role for TNKS1 as a key modulator of RBP-mediated post-transcriptional events required for vital processes such as myogenesis.
AB - Poly(ADP-ribosylation) (PARylation) is a post-translational modification mediated by a subset of ADP-ribosyl transferases (ARTs). Although PARylation-inhibition based therapies are considered as an avenue to combat debilitating diseases such as cancer and myopathies, the role of this modification in physiological processes such as cell differentiation remains unclear. Here, we show that Tankyrase1 (TNKS1), a PARylating ART, plays a major role in myogenesis, a vital process known to drive muscle fiber formation and regeneration. Although all bona fide PARPs are expressed in muscle cells, experiments using siRNA-mediated knockdown or pharmacological inhibition show that TNKS1 is the enzyme responsible of catalyzing PARylation during myogenesis. Via this activity, TNKS1 controls the turnover of mRNAs encoding myogenic regulatory factors such as nucleophosmin (NPM) and myogenin. TNKS1 mediates these effects by targeting RNA-binding proteins such as Human Antigen R (HuR). HuR harbors a conserved TNKS-binding motif (TBM), the mutation of which not only prevents the association of HuR with TNKS1 and its PARylation, but also precludes HuR from regulating the turnover of NPM and myogenin mRNAs as well as from promoting myogenesis. Therefore, our data uncover a new role for TNKS1 as a key modulator of RBP-mediated post-transcriptional events required for vital processes such as myogenesis.
UR - http://www.scopus.com/inward/record.url?scp=85191593303&partnerID=8YFLogxK
U2 - 10.1093/nar/gkae059
DO - 10.1093/nar/gkae059
M3 - Article
C2 - 38321934
AN - SCOPUS:85191593303
SN - 0305-1048
VL - 52
SP - 4002
EP - 4020
JO - NUCLEIC ACIDS RESEARCH
JF - NUCLEIC ACIDS RESEARCH
IS - 7
ER -